| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HOC.2010.08.007 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S088985881000119X?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:S088985881000119X?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 21075287 |
| P2093 | author name string | Y. M Dennis Lo | |
| Rossa W. K. Chiu | |||
| P2860 | cites work | Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. | Q54574187 |
| Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome | Q56765605 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21 | Q58029321 | ||
| Mass Spectrometric Detection of an SNP Panel as an Internal Positive Control for Fetal DNA Analysis in Maternal Plasma | Q58029391 | ||
| Noninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical Considerations | Q58029492 | ||
| Prenatal exclusion of β thalassaemia major by examination of maternal plasma | Q58029823 | ||
| Noninvasive prenatal exclusion of haemoglobin Bart's using foetal DNA from maternal plasma | Q60221702 | ||
| New strategy for prenatal diagnosis of X-linked disorders | Q74053620 | ||
| Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia | Q74446351 | ||
| Detection of fetal RHD-specific sequences in maternal plasma | Q77429872 | ||
| Mass spectrometry-based detection of hemoglobin E mutation by allele-specific base extension reaction | Q81472098 | ||
| Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms | Q82218765 | ||
| Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool | Q83387898 | ||
| Prenatal diagnosis of hemoglobin Bart's disease: what is the noninvasive approach? | Q95806327 | ||
| Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 | ||
| Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 | ||
| Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Digital PCR | Q24685020 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. | Q30704921 | ||
| Hypermethylation of RASSF1A in human and rhesus placentas | Q33275493 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry | Q33464117 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR | Q35215049 | ||
| PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies | Q35249607 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. | Q36986986 | ||
| Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma | Q37000915 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Non-invasive fetal sex determination: impact on clinical practice | Q37075333 | ||
| Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies | Q37164146 | ||
| Non-invasive prenatal diagnosis by single molecule counting technologies | Q37525261 | ||
| Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood | Q46167117 | ||
| Microsystem for isolation of fetal DNA from maternal plasma by preparative size separation | Q47172890 | ||
| Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma | Q47391690 | ||
| Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms | Q47423342 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. | Q47808590 | ||
| Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report | Q48004844 | ||
| Detection of aneuploidy with digital polymerase chain reaction | Q48567144 | ||
| Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. | Q51767524 | ||
| Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. | Q53063252 | ||
| Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis of beta-thalassemia: a feasibility study in southern Chinese. | Q54438535 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diagnosis | Q16644043 |
| P304 | page(s) | 1179-1186 | |
| P577 | publication date | 2010-09-29 | |
| P1433 | published in | Hematology / Oncology Clinics of North America | Q15749192 |
| P1476 | title | Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in maternal plasma | |
| Noninvasive Approaches to Prenatal Diagnosis of Hemoglobinopathies Using Fetal DNA in Maternal Plasma | |||
| P478 | volume | 24 |
| Q82261782 | Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma |
| Q38208530 | Non-invasive prenatal diagnosis: progress and potential |
| Q38088416 | Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges |
| Q38002933 | Noninvasive prenatal diagnosis of monogenic disorders |
| Q39708856 | Thalassaemia |
| Q38782082 | The future of academic haematology |
| Q38209384 | What does next-generation sequencing mean for prenatal diagnosis? |
Search more.